Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
Haiyan Chen,1 An Lu,1 Xiaoyi Zhang,1 Lin Gui,1 Yaonan Wang,1 Jianhui Wu,1 Hua Feng,1 Shiqi Peng,1 Ming Zhao1,2 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedic...
Saved in:
Main Authors: | Chen H (Author), Lu A (Author), Zhang X (Author), Gui L (Author), Wang YN (Author), Wu J (Author), Feng H (Author), Peng S (Author), Zhao M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin
by: Hui Wang, et al.
Published: (2023) -
LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa
by: Yi Kong, et al.
Published: (2015) -
Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.
by: Fidel Manuel Cáceres Lóriga, et al.
Published: (2001) -
Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group
by: S. B. Fitilev, et al.
Published: (2022) -
Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020)